Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Argus Health
US Army
US Department of Justice

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202147

« Back to Dashboard

NDA 202147 describes COSYNTROPIN, which is a drug marketed by Mylan Institutional, Sandoz, and Sandoz Inc, and is included in three NDAs. It is available from two suppliers. Additional details are available on the COSYNTROPIN profile page.

The generic ingredient in COSYNTROPIN is cosyntropin. There are two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cosyntropin profile page.
Summary for 202147
Formulation / Manufacturing:see details
Pharmacology for NDA: 202147
Medical Subject Heading (MeSH) Categories for 202147
Suppliers and Packaging for NDA: 202147
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
COSYNTROPIN cosyntropin INJECTABLE;INJECTION 202147 ANDA Sandoz Inc 0781-3440 N 0781-3440-95

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.25MG/VIAL
Approval Date:Jun 29, 2012TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
US Army
Chinese Patent Office
US Department of Justice
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.